RNAConnect, Inc. formally launches to drive RNA analysis

FHS
May 29, 2024
8:24 am

RNAConnect, a pioneering life science reagent company, officially launches today, promising groundbreaking solutions for exploring the real-world diversity of RNA sequence and structure.

BioCryst secures $69m contract from US to supply RAPIVAB for influenza

The injection has been approved in the US to treat simple flu cases in patients as young as six months. Credit: pedro7merino via Shutterstock. BioCryst

October 1, 2024

Lobe Sciences Announces Update | Psychedelic Invest

VANCOUVER, British Columbia, June 04, 2024–(BUSINESS WIRE)–Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines

June 5, 2024

Is Adding an AI Readout to Mammography Worth It?

More women may be getting an offer to add an artificial intelligence (AI) readout to their mammograms, but they’ll have to pay for it out-of-pocket

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.